Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Cell & Bioscience

Fig. 3

From: The influence of SARS-CoV-2 spike protein exposure on retinal development in the human retinal organoids

Fig. 3

The influence of the SARS-CoV-2 S protein exposure on the development of hEROs. A Schematic of S protein treatment of hEROs at different points. B The relative mRNA levels of ACE2 and TMP in hEROs at day 90 after S protein exposure, compared to control groups . C The relative mRNA levels of ACE2 and TMP in hEROs at day 280 after S protein exposure, compared to control groups . D Representative images of the expression of RECV+/ACE2+ cells and CRX+/ACE2+ cells in hEROs at days 90 and 280 after S protein exposure. E The ratio of CRX-positive cells/ area (μm2) and the average fluorescence intensity of RECV- positive cells in 90-day hEROs after S protein exposure, compared to control groups . F The ratio of CRX-positive cells/ area (μm2) and the average fluorescence intensity of RECV- positive cells in 280-day hEROs after S protein exposure, compared to control groups. Data are presented as means ± SD. Scale bar, 50 μm

Back to article page